Form DEF 14A TScan Therapeutics, Inc. For: Nov 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $26.80 | |||
| Open | $0.19 | 52 Week Low | $23.00 | |||
| Day High | $0.20 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $0.00 | |||
| Volume | 341,629 | |||||
